Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 713 | 1,007 | 0 | 0 |
| Operating Income | -713 | -1,007 | N/A | N/A |
| Other Income | 1,206 | 1,089 | 0 | 0 |
| Pre-tax Income | 493 | 82 | 0 | 0 |
| Income Tax | 84 | 16 | N/A | N/A |
| Net Income Continuous | 408 | 66 | N/A | N/A |
| Net Income | $408 | $66 | $N/A | $N/A |
| EPS Basic Total Ops | -1.10 | -2.90 | N/A | N/A |
| EPS Basic Continuous Ops | 1.47 | 0.25 | N/A | N/A |
| EPS Diluted Total Ops | -1.10 | -2.90 | N/A | N/A |
| EPS Diluted Continuous Ops | 1.47 | 0.25 | N/A | N/A |
| EBITDA(a) | $-713 | $-1,007 | $N/A | $N/A |